Review





Similar Products

94
Developmental Studies Hybridoma Bank mouse
Mouse, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
mouse - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

92
ATCC anti cd40 12b4 2c10
Anti Cd40 12b4 2c10, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd40 12b4 2c10/product/ATCC
Average 92 stars, based on 1 article reviews
anti cd40 12b4 2c10 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
Novus Biologicals antibodies against ube2o
HBc/capsid interacts with <t>UBE2O.</t> A , proximity ligation assay (PLA) using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bar, = 20 μm. B , PLA using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HepAD38 cells. Tet+, tetracycline-treated cells (low HBV production) and Tet-, tetracycline-untreated cells (high HBV production). Nuclei were counterstained with DAPI. Bar, = 20 μm. C , HepG2-NTCP cells were transfected with Flag-Myc-tagged UBE2O and 2 days post-transfection infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) using anti-HBc or anti-capsid (Hyb-3120) antibodies and analyzed by Western blotting (WB) with anti-Flag and anti-HBc antibodies. The expression levels of UBE2O and HBc are shown for comparison (input). D , HepG2-NTCP cells were infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) with anti-UBE2O antibodies (lanes one and 2) or an isotype control antibody (lane 3) and analyzed by Western blotting (WB) with anti-HBc and anti-UBE2O antibodies. The expression levels of endogenous UBE2O, HBc and β-actin are shown for comparison (input). E , UBE2O interacts with both capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A, Y132A/S164A/S172A, and W102A) HBc variants. HepG2-NTCP cells were co-transfected with Flag-Myc-tagged UBE2O and wt-HBc or its mutant variants, as indicated. Two days post-transfection, protein lysates were immunoprecipitated (IP) with anti-HBc or anti-Flag antibodies and analyzed by Western blotting (WB) with anti-Flag or anti-HBc antibodies, respectively. The expression levels of UBE2O and HBc are shown for comparison (input). F , the PLA assay was performed using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against hypo-pHBc in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bars, = 20 μm.
Antibodies Against Ube2o, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against ube2o/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
antibodies against ube2o - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Virusys Inc mouse anti-gd ab clone 2c10
HBc/capsid interacts with <t>UBE2O.</t> A , proximity ligation assay (PLA) using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bar, = 20 μm. B , PLA using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HepAD38 cells. Tet+, tetracycline-treated cells (low HBV production) and Tet-, tetracycline-untreated cells (high HBV production). Nuclei were counterstained with DAPI. Bar, = 20 μm. C , HepG2-NTCP cells were transfected with Flag-Myc-tagged UBE2O and 2 days post-transfection infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) using anti-HBc or anti-capsid (Hyb-3120) antibodies and analyzed by Western blotting (WB) with anti-Flag and anti-HBc antibodies. The expression levels of UBE2O and HBc are shown for comparison (input). D , HepG2-NTCP cells were infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) with anti-UBE2O antibodies (lanes one and 2) or an isotype control antibody (lane 3) and analyzed by Western blotting (WB) with anti-HBc and anti-UBE2O antibodies. The expression levels of endogenous UBE2O, HBc and β-actin are shown for comparison (input). E , UBE2O interacts with both capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A, Y132A/S164A/S172A, and W102A) HBc variants. HepG2-NTCP cells were co-transfected with Flag-Myc-tagged UBE2O and wt-HBc or its mutant variants, as indicated. Two days post-transfection, protein lysates were immunoprecipitated (IP) with anti-HBc or anti-Flag antibodies and analyzed by Western blotting (WB) with anti-Flag or anti-HBc antibodies, respectively. The expression levels of UBE2O and HBc are shown for comparison (input). F , the PLA assay was performed using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against hypo-pHBc in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bars, = 20 μm.
Mouse Anti Gd Ab Clone 2c10, supplied by Virusys Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-gd ab clone 2c10/product/Virusys Inc
Average 90 stars, based on 1 article reviews
mouse anti-gd ab clone 2c10 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
Developmental Studies Hybridoma Bank olig2
kcnb1 is expressed in distinct cell subtypes and various regions of the central nervous system in 6 days post fertilization (dpf) wild‐type (WT) zebrafish. (A, B) Horizontal and transversal sections of WT zebrafish expressing cells (4,6‐diamidino‐2‐phenylindole [DAPI]; blue) labeled with anti‐kcnb1 (green), showing a large expression of the protein in the central nervous system (CNS) at 6 dpf. The protein is expressed in the telencephalon, diencephalon, midbrain including the optic tectum, and hindbrain comprising the cerebellum and the spinal cord (A: scale bar = 50 μm, magnification = 10×; B: scale bar = 30 μm, magnification 20×). (C) Horizontal section of a WT zebrafish at 6 dpf showing the presence of kcnb1 along the spinal cord (scale bar = 10 μm, magnification = 63×). (D–F) Horizontal sections of 6‐dpf WT zebrafish expressing cells (DAPI; blue), kcnb1 (green), and specific cell subtype markers, respectively. (D) A neuronal nuclear marker (neuronal nuclear antigen [NeuN]; red, scale bar = 30 μm, magnification = 20×), (E) oligodendrocyte transcription factor 2 <t>(Olig2;</t> red, scale bar = 10 μm, magnification = 63×), and (F) CX3C motif chemokine receptor 1 expressed in microglial cells (CX3CR1; red, scale bar = 10 μm, magnification = 63×). Images demonstrate the colocalization between kcnb1 and the three different cell subtype markers, represented in white and marked by arrows. These results indicate the presence of kcnb1 in neurons, oligodendrocytes, and microglial cells. The colocalization was determined using Z ‐stack projection with IMARIS v10.1.0 software (Oxford Instruments). In figures, CNS regions are delimited by dotted lines. D, diencephalon; E, eyes; H, hindbrain; M: midbrain; T, telencephalon. n = 3–4/section.
Olig2, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/olig2/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
olig2 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
Thermo Fisher anti-fha (2c10) mabs
kcnb1 is expressed in distinct cell subtypes and various regions of the central nervous system in 6 days post fertilization (dpf) wild‐type (WT) zebrafish. (A, B) Horizontal and transversal sections of WT zebrafish expressing cells (4,6‐diamidino‐2‐phenylindole [DAPI]; blue) labeled with anti‐kcnb1 (green), showing a large expression of the protein in the central nervous system (CNS) at 6 dpf. The protein is expressed in the telencephalon, diencephalon, midbrain including the optic tectum, and hindbrain comprising the cerebellum and the spinal cord (A: scale bar = 50 μm, magnification = 10×; B: scale bar = 30 μm, magnification 20×). (C) Horizontal section of a WT zebrafish at 6 dpf showing the presence of kcnb1 along the spinal cord (scale bar = 10 μm, magnification = 63×). (D–F) Horizontal sections of 6‐dpf WT zebrafish expressing cells (DAPI; blue), kcnb1 (green), and specific cell subtype markers, respectively. (D) A neuronal nuclear marker (neuronal nuclear antigen [NeuN]; red, scale bar = 30 μm, magnification = 20×), (E) oligodendrocyte transcription factor 2 <t>(Olig2;</t> red, scale bar = 10 μm, magnification = 63×), and (F) CX3C motif chemokine receptor 1 expressed in microglial cells (CX3CR1; red, scale bar = 10 μm, magnification = 63×). Images demonstrate the colocalization between kcnb1 and the three different cell subtype markers, represented in white and marked by arrows. These results indicate the presence of kcnb1 in neurons, oligodendrocytes, and microglial cells. The colocalization was determined using Z ‐stack projection with IMARIS v10.1.0 software (Oxford Instruments). In figures, CNS regions are delimited by dotted lines. D, diencephalon; E, eyes; H, hindbrain; M: midbrain; T, telencephalon. n = 3–4/section.
Anti Fha (2c10) Mabs, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-fha (2c10) mabs/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-fha (2c10) mabs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Virusys Inc anti-hsv-1/2 gd clone 2c10 ha025-100
kcnb1 is expressed in distinct cell subtypes and various regions of the central nervous system in 6 days post fertilization (dpf) wild‐type (WT) zebrafish. (A, B) Horizontal and transversal sections of WT zebrafish expressing cells (4,6‐diamidino‐2‐phenylindole [DAPI]; blue) labeled with anti‐kcnb1 (green), showing a large expression of the protein in the central nervous system (CNS) at 6 dpf. The protein is expressed in the telencephalon, diencephalon, midbrain including the optic tectum, and hindbrain comprising the cerebellum and the spinal cord (A: scale bar = 50 μm, magnification = 10×; B: scale bar = 30 μm, magnification 20×). (C) Horizontal section of a WT zebrafish at 6 dpf showing the presence of kcnb1 along the spinal cord (scale bar = 10 μm, magnification = 63×). (D–F) Horizontal sections of 6‐dpf WT zebrafish expressing cells (DAPI; blue), kcnb1 (green), and specific cell subtype markers, respectively. (D) A neuronal nuclear marker (neuronal nuclear antigen [NeuN]; red, scale bar = 30 μm, magnification = 20×), (E) oligodendrocyte transcription factor 2 <t>(Olig2;</t> red, scale bar = 10 μm, magnification = 63×), and (F) CX3C motif chemokine receptor 1 expressed in microglial cells (CX3CR1; red, scale bar = 10 μm, magnification = 63×). Images demonstrate the colocalization between kcnb1 and the three different cell subtype markers, represented in white and marked by arrows. These results indicate the presence of kcnb1 in neurons, oligodendrocytes, and microglial cells. The colocalization was determined using Z ‐stack projection with IMARIS v10.1.0 software (Oxford Instruments). In figures, CNS regions are delimited by dotted lines. D, diencephalon; E, eyes; H, hindbrain; M: midbrain; T, telencephalon. n = 3–4/section.
Anti Hsv 1/2 Gd Clone 2c10 Ha025 100, supplied by Virusys Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hsv-1/2 gd clone 2c10 ha025-100/product/Virusys Inc
Average 90 stars, based on 1 article reviews
anti-hsv-1/2 gd clone 2c10 ha025-100 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
R&D Systems anti ccr8 antibody
Fig. 5 | <t>CCL17–CCR8–CCL3</t> axis critically interferes with Treg differentiation. a, Schematic of co-culture experiment, where isolated splenic CD4+CD62L+ T cells from Ccr8WTApoe−/− or Ccr8KOApoe−/− mice were combined with sorted CD11c+MHCII+ cDCs from LN of CCR8WTApoe−/− mice and cultured for 3 d in the absence or presence of recombinant murine CCL17 (100 ng ml−1). b, CCL3 concentrations were measured in cell supernatants by ELISA (number of independent experiments per bar from left to right, n = 7, 9, 6, 9). c, CD4+CD25+Foxp3+ Treg cells were quantified using flow cytometry analysis (number of independent experiments per bar from left to right: n = 10, 12, 10 and 13). d, Scheme of co-culture experiment, where isolated splenic CD4+CD62L+ T cells from Ccr8WTApoe−/− or Ccr8KOApoe−/−mice were combined with sorted CD11c+MHCII+ cDCs from LN of Apoe−/− or Apoe−/−Ccl17e/e mice and cultured for 3 d. e, CCL3 concentrations in the supernatant were determined by ELISA
Anti Ccr8 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ccr8 antibody/product/R&D Systems
Average 94 stars, based on 1 article reviews
anti ccr8 antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


HBc/capsid interacts with UBE2O. A , proximity ligation assay (PLA) using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bar, = 20 μm. B , PLA using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HepAD38 cells. Tet+, tetracycline-treated cells (low HBV production) and Tet-, tetracycline-untreated cells (high HBV production). Nuclei were counterstained with DAPI. Bar, = 20 μm. C , HepG2-NTCP cells were transfected with Flag-Myc-tagged UBE2O and 2 days post-transfection infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) using anti-HBc or anti-capsid (Hyb-3120) antibodies and analyzed by Western blotting (WB) with anti-Flag and anti-HBc antibodies. The expression levels of UBE2O and HBc are shown for comparison (input). D , HepG2-NTCP cells were infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) with anti-UBE2O antibodies (lanes one and 2) or an isotype control antibody (lane 3) and analyzed by Western blotting (WB) with anti-HBc and anti-UBE2O antibodies. The expression levels of endogenous UBE2O, HBc and β-actin are shown for comparison (input). E , UBE2O interacts with both capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A, Y132A/S164A/S172A, and W102A) HBc variants. HepG2-NTCP cells were co-transfected with Flag-Myc-tagged UBE2O and wt-HBc or its mutant variants, as indicated. Two days post-transfection, protein lysates were immunoprecipitated (IP) with anti-HBc or anti-Flag antibodies and analyzed by Western blotting (WB) with anti-Flag or anti-HBc antibodies, respectively. The expression levels of UBE2O and HBc are shown for comparison (input). F , the PLA assay was performed using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against hypo-pHBc in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bars, = 20 μm.

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: HBc/capsid interacts with UBE2O. A , proximity ligation assay (PLA) using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bar, = 20 μm. B , PLA using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against UBE2O in HepAD38 cells. Tet+, tetracycline-treated cells (low HBV production) and Tet-, tetracycline-untreated cells (high HBV production). Nuclei were counterstained with DAPI. Bar, = 20 μm. C , HepG2-NTCP cells were transfected with Flag-Myc-tagged UBE2O and 2 days post-transfection infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) using anti-HBc or anti-capsid (Hyb-3120) antibodies and analyzed by Western blotting (WB) with anti-Flag and anti-HBc antibodies. The expression levels of UBE2O and HBc are shown for comparison (input). D , HepG2-NTCP cells were infected with HBV, as indicated. Six days post-infection, protein lysates were immunoprecipitated (IP) with anti-UBE2O antibodies (lanes one and 2) or an isotype control antibody (lane 3) and analyzed by Western blotting (WB) with anti-HBc and anti-UBE2O antibodies. The expression levels of endogenous UBE2O, HBc and β-actin are shown for comparison (input). E , UBE2O interacts with both capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A, Y132A/S164A/S172A, and W102A) HBc variants. HepG2-NTCP cells were co-transfected with Flag-Myc-tagged UBE2O and wt-HBc or its mutant variants, as indicated. Two days post-transfection, protein lysates were immunoprecipitated (IP) with anti-HBc or anti-Flag antibodies and analyzed by Western blotting (WB) with anti-Flag or anti-HBc antibodies, respectively. The expression levels of UBE2O and HBc are shown for comparison (input). F , the PLA assay was performed using a mouse antibody against the HBV capsid (Hyb-3120) and a rabbit antibody against hypo-pHBc in HBV-infected HepG2-NTCP cells at day 6 post-infection. Nuclei were counterstained with DAPI. Bars, = 20 μm.

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Proximity Ligation Assay, Infection, Transfection, Immunoprecipitation, Western Blot, Expressing, Comparison, Control, Mutagenesis

Inhibition of UBE2O expression reduces HBV replication and secretion of HBe antigen in infected HepG2-NTCP cells . A , experimental outline: HepG2-NTCP cells or primary human hepatocytes (PHH; in ) were transfected with control (si_ctrl-A, si_ctrl-B) or UBE2O-specific (si_UBE2O-A, si_UBE2O-B and si_UBE2O-C) siRNAs. Two days after transfection, the cells were infected with the HBV. Six days post-infection, the cells and media were harvested to quantify the expression levels of UBE2O (in B ), intracellular total HBV DNA (in C ), cccDNA (in D ), pgRNA (in E ), and the extracellular HBe antigen (in F ). Data are presented as the mean ± SD from three independent experiments. Color-coded data points distinguish individual replicates from each experiment, and colored horizontal lines indicate the mean values. Statistical significance of differences between UBE2O silencing and control (si_ctrl-A) groups was evaluated by 2-way ANOVA ( p ≥ 0.05 – not significant (ns); ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001).

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: Inhibition of UBE2O expression reduces HBV replication and secretion of HBe antigen in infected HepG2-NTCP cells . A , experimental outline: HepG2-NTCP cells or primary human hepatocytes (PHH; in ) were transfected with control (si_ctrl-A, si_ctrl-B) or UBE2O-specific (si_UBE2O-A, si_UBE2O-B and si_UBE2O-C) siRNAs. Two days after transfection, the cells were infected with the HBV. Six days post-infection, the cells and media were harvested to quantify the expression levels of UBE2O (in B ), intracellular total HBV DNA (in C ), cccDNA (in D ), pgRNA (in E ), and the extracellular HBe antigen (in F ). Data are presented as the mean ± SD from three independent experiments. Color-coded data points distinguish individual replicates from each experiment, and colored horizontal lines indicate the mean values. Statistical significance of differences between UBE2O silencing and control (si_ctrl-A) groups was evaluated by 2-way ANOVA ( p ≥ 0.05 – not significant (ns); ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001).

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Inhibition, Expressing, Infection, Transfection, Control

UBE2O knockdown in HBV-infected HepG2-NTCP cells led to the inhibition of intracellular nucleocapsid assembly and the secretion of enveloped virions . HepG2-NTCP cells were transfected with two control and three UBE2O-specific siRNAs. Two days post-transfection, the cells were infected with the HBV according to the experimental outline shown in A . Six days post-infection, the cells and media were harvested for analyses of nucleocapsid assembly and virion secretion. A , the protein extracts isolated from HBV-infected HepG2-NTCP cells were analyzed by Western blotting (WB; input) and subjected to immunoprecipitation with anti-capsid (Hyb-3120) antibodies (IP: capsid, WB: HBc). B , downregulation of UBE2O expression in infected HepG2-NTCP cells resulted in decreased levels of intracellular DNA-containing nucleocapsids. Nucleocapsids were immunoprecipitated from protein lysates using anti-capsid antibodies and quantified via qPCR. C , Downregulation of UBE2O expression in infected HepG2-NTCP cells resulted in decreased levels of secreted enveloped virions. Viral particles were immunoprecipitated from the cell culture supernatants using anti-S antibodies and quantified via qPCR. D , the secretion of naked nucleocapsids was not affected by UBE2O downregulation. Naked nucleocapsids were immunoprecipitated from the cell culture supernatants using anti-capsid antibodies, followed by quantification via qPCR. In (B-D), data are presented as the mean ± SD from three independent experiments. Color-coded data points distinguish individual replicates from each experiment, and colored horizontal lines indicate the mean values. The statistical significance of differences between UBE2O silencing and control (si_ctrl-A) groups was evaluated by 2-way ANOVA ( p ≥ 0.05 – not significant (ns); ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001).

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: UBE2O knockdown in HBV-infected HepG2-NTCP cells led to the inhibition of intracellular nucleocapsid assembly and the secretion of enveloped virions . HepG2-NTCP cells were transfected with two control and three UBE2O-specific siRNAs. Two days post-transfection, the cells were infected with the HBV according to the experimental outline shown in A . Six days post-infection, the cells and media were harvested for analyses of nucleocapsid assembly and virion secretion. A , the protein extracts isolated from HBV-infected HepG2-NTCP cells were analyzed by Western blotting (WB; input) and subjected to immunoprecipitation with anti-capsid (Hyb-3120) antibodies (IP: capsid, WB: HBc). B , downregulation of UBE2O expression in infected HepG2-NTCP cells resulted in decreased levels of intracellular DNA-containing nucleocapsids. Nucleocapsids were immunoprecipitated from protein lysates using anti-capsid antibodies and quantified via qPCR. C , Downregulation of UBE2O expression in infected HepG2-NTCP cells resulted in decreased levels of secreted enveloped virions. Viral particles were immunoprecipitated from the cell culture supernatants using anti-S antibodies and quantified via qPCR. D , the secretion of naked nucleocapsids was not affected by UBE2O downregulation. Naked nucleocapsids were immunoprecipitated from the cell culture supernatants using anti-capsid antibodies, followed by quantification via qPCR. In (B-D), data are presented as the mean ± SD from three independent experiments. Color-coded data points distinguish individual replicates from each experiment, and colored horizontal lines indicate the mean values. The statistical significance of differences between UBE2O silencing and control (si_ctrl-A) groups was evaluated by 2-way ANOVA ( p ≥ 0.05 – not significant (ns); ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001).

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Knockdown, Infection, Inhibition, Transfection, Control, Isolation, Western Blot, Immunoprecipitation, Expressing, Cell Culture

UBE2O and viral capsids associate with MVBs in HBV-infected HepG2-NTCP cells. A–F , HepG2-NTCP cells were either infected with HBV or maintained as uninfected controls. Six days post-infection, cells were immunostained for confocal microscopy analysis (in A–E ) or subjected to PLA (in F ). A , HBV-infected HepG2-NTCP cells were immunostained with anti-capsid ( red ) and anti-UBE2O ( green ) antibodies. White squares indicate enlarged areas of UBE2O and HBV capsid co-localization shown on the right . Nuclei were counterstained with DAPI. Bar, = 10 μm. B , colocalization of HBV capsids ( red ) with CD63 or TSG101 (both green ) in HBV-infected HepG2-NTCP cells. DAPI was used for nuclear staining. Bars, = 10 μm. C , HBV-infected or ( D ) uninfected HepG2-NTCP cells were stained with antibodies against UBE2O ( green ) and CD63 ( red ). White squares indicate enlarged regions of UBE2O and CD63 co-localization, as shown on the right . Nuclei were counterstained with DAPI. Bars, = 10 μm. E , confocal section of HBV-infected HepG2-NTCP cells. Ubiquitin ( red ) and UBE2O ( green ) were stained with specific antibodies, and nuclei were stained with DAPI. White squares indicate enlarged areas of UBE2O and ubiquitinated proteins co-localization, shown on the right . Bars, = 10 μm. F , PLA of the interaction between UBE2O and CD63 in HBV-infected HepG2-NTCP cells was measured 6 days post-infection using Duolink PLA reagents. A mouse isotype antibody was used as a control. Nuclei were counterstained with DAPI. Bars, = 20 μm. G , HepG2-NTCP cells were transfected with wt-HBc, Flag-Myc-tagged wt-UBE2O, Flag-tagged SNF8/EAP30, or Flag-tagged HGS, as indicated. Isolated protein lysates were subjected to immunoprecipitation with anti-capsid antibodies followed by Western blotting with anti-Flag antibodies to detect HGS, SNF8 and UBE2O. The expression levels of transfected proteins were analyzed by Western blotting ( bottom panels ; WB: Flag and WB: HBc). ∗, IgG heavy chain.

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: UBE2O and viral capsids associate with MVBs in HBV-infected HepG2-NTCP cells. A–F , HepG2-NTCP cells were either infected with HBV or maintained as uninfected controls. Six days post-infection, cells were immunostained for confocal microscopy analysis (in A–E ) or subjected to PLA (in F ). A , HBV-infected HepG2-NTCP cells were immunostained with anti-capsid ( red ) and anti-UBE2O ( green ) antibodies. White squares indicate enlarged areas of UBE2O and HBV capsid co-localization shown on the right . Nuclei were counterstained with DAPI. Bar, = 10 μm. B , colocalization of HBV capsids ( red ) with CD63 or TSG101 (both green ) in HBV-infected HepG2-NTCP cells. DAPI was used for nuclear staining. Bars, = 10 μm. C , HBV-infected or ( D ) uninfected HepG2-NTCP cells were stained with antibodies against UBE2O ( green ) and CD63 ( red ). White squares indicate enlarged regions of UBE2O and CD63 co-localization, as shown on the right . Nuclei were counterstained with DAPI. Bars, = 10 μm. E , confocal section of HBV-infected HepG2-NTCP cells. Ubiquitin ( red ) and UBE2O ( green ) were stained with specific antibodies, and nuclei were stained with DAPI. White squares indicate enlarged areas of UBE2O and ubiquitinated proteins co-localization, shown on the right . Bars, = 10 μm. F , PLA of the interaction between UBE2O and CD63 in HBV-infected HepG2-NTCP cells was measured 6 days post-infection using Duolink PLA reagents. A mouse isotype antibody was used as a control. Nuclei were counterstained with DAPI. Bars, = 20 μm. G , HepG2-NTCP cells were transfected with wt-HBc, Flag-Myc-tagged wt-UBE2O, Flag-tagged SNF8/EAP30, or Flag-tagged HGS, as indicated. Isolated protein lysates were subjected to immunoprecipitation with anti-capsid antibodies followed by Western blotting with anti-Flag antibodies to detect HGS, SNF8 and UBE2O. The expression levels of transfected proteins were analyzed by Western blotting ( bottom panels ; WB: Flag and WB: HBc). ∗, IgG heavy chain.

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Infection, Confocal Microscopy, Staining, Ubiquitin Proteomics, Control, Transfection, Isolation, Immunoprecipitation, Western Blot, Expressing

UBE2O mediates the monoubiquitination of hypophosphorylated HBc localized in the cytoplasm . A , HepG2-NTCP cells were transfected with HA-tagged ubiquitin (HA-Ub) together with Flag-Myc-tagged wt-UBE2O and various wt-HBc expression plasmids that were either untagged (HBc) or tagged at the N-terminus (His-Flag-HBc) or the C-terminus (HBc-Flag). Forty-eight hours after transfection, the cells were fractionated into nuclear ( left ) and cytoplasmic ( right ) extracts. The protein lysates were denatured in 2% SDS and analyzed by immunoprecipitation (IP: anti-HA) followed by Western blotting (WB: hyper-pHBc, HBc and hypo-pHBc). The expression levels of HBc, UBE2O, ubiquitin, lamin A/C (nuclear marker), α-tubulin (cytoplasmic marker) and β-actin (loading control) were analyzed in the input samples. B , the catalytically-defective mutant UBE2O-CD (UBE2O-C1040S) lost the ability to ubiquitinate the HBc/capsids. HepG2-NTCP cells were transfected with HA-tagged ubiquitin, wt-HBc and Flag-Myc-tagged UBE2O-wt or UBE2O-CD. The whole cell lysates were isolated, denatured and analyzed as in ( A ). C , in vitro ubiquitination of wt-HBc with 400 nM UBE2O, 75 nM E1 enzyme, 5 μM ubiquitin-wt (Ub-WT) or methylated ubiquitin (Methyl-Ub). Western blotting with anti-HBc antibodies was used to visualize ubiquitinated HBc, representative of two replicates. D and E , immunoprecipitation and Western blot analysis of cellular lysates from HepG2-NTCP cells transfected with wt-HBc, Flag-Myc-tagged wt-UBE2O and HA-tagged single K (in D ) or K-to-R (in E ) ubiquitin mutants. The ubiquitinated proteins were precipitated with anti-HA antibodies (IP: HA) and analyzed by Western blotting with anti-HBc or anti-hypo-pHBc.

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: UBE2O mediates the monoubiquitination of hypophosphorylated HBc localized in the cytoplasm . A , HepG2-NTCP cells were transfected with HA-tagged ubiquitin (HA-Ub) together with Flag-Myc-tagged wt-UBE2O and various wt-HBc expression plasmids that were either untagged (HBc) or tagged at the N-terminus (His-Flag-HBc) or the C-terminus (HBc-Flag). Forty-eight hours after transfection, the cells were fractionated into nuclear ( left ) and cytoplasmic ( right ) extracts. The protein lysates were denatured in 2% SDS and analyzed by immunoprecipitation (IP: anti-HA) followed by Western blotting (WB: hyper-pHBc, HBc and hypo-pHBc). The expression levels of HBc, UBE2O, ubiquitin, lamin A/C (nuclear marker), α-tubulin (cytoplasmic marker) and β-actin (loading control) were analyzed in the input samples. B , the catalytically-defective mutant UBE2O-CD (UBE2O-C1040S) lost the ability to ubiquitinate the HBc/capsids. HepG2-NTCP cells were transfected with HA-tagged ubiquitin, wt-HBc and Flag-Myc-tagged UBE2O-wt or UBE2O-CD. The whole cell lysates were isolated, denatured and analyzed as in ( A ). C , in vitro ubiquitination of wt-HBc with 400 nM UBE2O, 75 nM E1 enzyme, 5 μM ubiquitin-wt (Ub-WT) or methylated ubiquitin (Methyl-Ub). Western blotting with anti-HBc antibodies was used to visualize ubiquitinated HBc, representative of two replicates. D and E , immunoprecipitation and Western blot analysis of cellular lysates from HepG2-NTCP cells transfected with wt-HBc, Flag-Myc-tagged wt-UBE2O and HA-tagged single K (in D ) or K-to-R (in E ) ubiquitin mutants. The ubiquitinated proteins were precipitated with anti-HA antibodies (IP: HA) and analyzed by Western blotting with anti-HBc or anti-hypo-pHBc.

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Transfection, Ubiquitin Proteomics, Expressing, Immunoprecipitation, Western Blot, Marker, Control, Mutagenesis, Isolation, In Vitro, Methylation

Inhibition of HBc/capsid phosphorylation at S164 and S172 enhances UBE2O-mediated monoubiquitination of HBc/capsid . A , top –Schematic representation of serine-to-alanine mutations in the CTD of HBc. The sequence of wild-type HBc corresponds to HBV genotype A, subtype adw2. Bottom – Analysis of UBE2O-mediated ubiquitination of single or multiple S-to-A HBc mutants. The images display analysis of denatured whole cell lysates immunoprecipitated with anti-HA antibodies (IP: anti-HA) and analyzed by Western blotting with anti-HBc antibodies. B , analysis of UBE2O-mediated ubiquitination of both capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A, Y132A/S164A/S172A, and W102A) HBc mutants. The images display analyses of denatured whole cell lysates immunoprecipitated with anti-HA antibodies (IP: anti-HA) and analyzed by Western blotting with anti-HBc and anti-hypo-pHBc antibodies. C , downregulation of UBE2O led to reduced HBc ubiquitination. HepG2-NTCP cells were transfected with control and UBE2O-specific siRNAs together with HA-Ub, wt-HBc, or S172A-HBc mutant. Denatured protein lysates were immunoprecipitated with anti-HA (Ub) antibodies and precipitated complexes were analyzed by Western blotting with anti-hypo-pHBc antibodies. The expression levels of UBE2O, HBc and ubiquitin were analyzed in the input samples. D , monoubiquitinated HBc assembles into capsids. HepG2-NTCP cells were transfected with wt-HBc, Flag-Myc-tagged wt-UBE2O and HA-tagged ubiquitin, as indicated. The cytoplasmic lysates were subjected to immunoprecipitation with anti-capsid antibodies (IP: anti-capsid, panels on the left, lanes one–4), followed by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc. The expression levels of HBc, ubiquitin and UBE2O were analyzed by Western blotting (input, panels on the right , lanes five–8).

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: Inhibition of HBc/capsid phosphorylation at S164 and S172 enhances UBE2O-mediated monoubiquitination of HBc/capsid . A , top –Schematic representation of serine-to-alanine mutations in the CTD of HBc. The sequence of wild-type HBc corresponds to HBV genotype A, subtype adw2. Bottom – Analysis of UBE2O-mediated ubiquitination of single or multiple S-to-A HBc mutants. The images display analysis of denatured whole cell lysates immunoprecipitated with anti-HA antibodies (IP: anti-HA) and analyzed by Western blotting with anti-HBc antibodies. B , analysis of UBE2O-mediated ubiquitination of both capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A, Y132A/S164A/S172A, and W102A) HBc mutants. The images display analyses of denatured whole cell lysates immunoprecipitated with anti-HA antibodies (IP: anti-HA) and analyzed by Western blotting with anti-HBc and anti-hypo-pHBc antibodies. C , downregulation of UBE2O led to reduced HBc ubiquitination. HepG2-NTCP cells were transfected with control and UBE2O-specific siRNAs together with HA-Ub, wt-HBc, or S172A-HBc mutant. Denatured protein lysates were immunoprecipitated with anti-HA (Ub) antibodies and precipitated complexes were analyzed by Western blotting with anti-hypo-pHBc antibodies. The expression levels of UBE2O, HBc and ubiquitin were analyzed in the input samples. D , monoubiquitinated HBc assembles into capsids. HepG2-NTCP cells were transfected with wt-HBc, Flag-Myc-tagged wt-UBE2O and HA-tagged ubiquitin, as indicated. The cytoplasmic lysates were subjected to immunoprecipitation with anti-capsid antibodies (IP: anti-capsid, panels on the left, lanes one–4), followed by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc. The expression levels of HBc, ubiquitin and UBE2O were analyzed by Western blotting (input, panels on the right , lanes five–8).

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Inhibition, Phospho-proteomics, Sequencing, Ubiquitin Proteomics, Immunoprecipitation, Western Blot, Transfection, Control, Mutagenesis, Expressing

UBE2O stimulates HBc/capsid secretion . A and B , analysis of capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A and Y132A/S164A/S172A) HBc variants’ secretion. HepG2-NTCP cells were co-transfected with UBE2O-wt and HBc variants, as indicated. A , the expression levels of intracellular UBE2O and HBc in protein lysates were determined by Western blotting (WB; input). The ability of HBc variants to assemble into capsids was examined by immunoprecipitation with anti-capsid (Hyb-3120) antibodies (IP: capsid; WB: HBc). B , the levels of secreted HBc were analyzed in the cell culture supernatants of transfected cells by Western blotting with HBc, hyper-pHBc and hypo-pHBc antibodies (Extracellular). Graph – Quantification of secreted HBc levels was performed by densitometric analysis of Western blots probed with anti-HBc antibodies, using ImageQuant TL Array software. The data are presented as means ± SDs of one experiment performed in biological replicates (n = 3) shown by orange points. The statistical significance of differences between the control and UBE2O-wt or UBE2O-CD groups was evaluated by a two-tailed t test (∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001). C and D , effect of UBE2O-wt and catalytically-defective (CD) mutant on the secretion of HBc and Ub-fused HBc. C , HepG2-NTCP cells were co-transfected with UBE2O-wt or -CD together with HBc (WT) and Ub-fused HBc (Ub-WT) variant, as indicated. The isolated cytoplasmic protein extracts (Intracellular) were analyzed by immunoprecipitation with anti-Flag (IP:Flag) or anti-HBc (IP:HBc) antibodies followed by Western blotting with anti-HBc or anti-Flag, respectively. The expression levels of UBE2O, HBc, and β-actin (loading control) were analyzed in the input samples (input). D , the levels of secreted HBc and Ub-HBc were analyzed in the medium of transfected cells by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc antibodies (Extracellular). Graph–Quantitative analysis of secreted HBc and Ub-HBc determined by ELISA in the cell culture supernatants. The data are presented as means ± SDs of one experiment performed in biological replicates (n = 3) shown by orange points. The statistical significance of differences between the control and UBE2O-wt or UBE2O-CD groups was evaluated by a two-tailed t test ( p ≥ 0.05–not significant (ns); ∗∗ p < 0.01).

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: UBE2O stimulates HBc/capsid secretion . A and B , analysis of capsid assembly-competent (wt, S164A/S172A, and Y132F) and capsid assembly-defective (Y132A and Y132A/S164A/S172A) HBc variants’ secretion. HepG2-NTCP cells were co-transfected with UBE2O-wt and HBc variants, as indicated. A , the expression levels of intracellular UBE2O and HBc in protein lysates were determined by Western blotting (WB; input). The ability of HBc variants to assemble into capsids was examined by immunoprecipitation with anti-capsid (Hyb-3120) antibodies (IP: capsid; WB: HBc). B , the levels of secreted HBc were analyzed in the cell culture supernatants of transfected cells by Western blotting with HBc, hyper-pHBc and hypo-pHBc antibodies (Extracellular). Graph – Quantification of secreted HBc levels was performed by densitometric analysis of Western blots probed with anti-HBc antibodies, using ImageQuant TL Array software. The data are presented as means ± SDs of one experiment performed in biological replicates (n = 3) shown by orange points. The statistical significance of differences between the control and UBE2O-wt or UBE2O-CD groups was evaluated by a two-tailed t test (∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001). C and D , effect of UBE2O-wt and catalytically-defective (CD) mutant on the secretion of HBc and Ub-fused HBc. C , HepG2-NTCP cells were co-transfected with UBE2O-wt or -CD together with HBc (WT) and Ub-fused HBc (Ub-WT) variant, as indicated. The isolated cytoplasmic protein extracts (Intracellular) were analyzed by immunoprecipitation with anti-Flag (IP:Flag) or anti-HBc (IP:HBc) antibodies followed by Western blotting with anti-HBc or anti-Flag, respectively. The expression levels of UBE2O, HBc, and β-actin (loading control) were analyzed in the input samples (input). D , the levels of secreted HBc and Ub-HBc were analyzed in the medium of transfected cells by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc antibodies (Extracellular). Graph–Quantitative analysis of secreted HBc and Ub-HBc determined by ELISA in the cell culture supernatants. The data are presented as means ± SDs of one experiment performed in biological replicates (n = 3) shown by orange points. The statistical significance of differences between the control and UBE2O-wt or UBE2O-CD groups was evaluated by a two-tailed t test ( p ≥ 0.05–not significant (ns); ∗∗ p < 0.01).

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Transfection, Expressing, Western Blot, Immunoprecipitation, Cell Culture, Software, Control, Two Tailed Test, Mutagenesis, Variant Assay, Isolation, Enzyme-linked Immunosorbent Assay

UBE2O mediates HBc/capsid multi-monoubiquitination and secretion. A , UBE2O stimulates HBc and capsid monoubiquitination and multi-monoubiquitination. HepG2-NTCP cells were transfected with Flag-Myc-tagged UBE2O-wt (UBE2O upregulation) together with HA-tagged ubiquitin and various HBc (WT, Y132A, and S164A) or Ub-HBc (Ub-WT, Ub-Y132A, and Ub-S164A) variants. The denatured whole cell lysates were immunoprecipitated with anti-HA antibodies (IP: anti-HA) and analyzed by Western blotting with anti-hypo-pHBc antibodies. The expression levels of UBE2O, HBc, and β-actin (loading control) were analyzed in the input samples (input). B , UBE2O depletion leads to the reduction of HBc and capsid monoubiquitination and multi-monoubiquitination. HepG2-NTCP cells were transfected with UBE2O-specific siRNA (si_UBE2O-B; UBE2O downregulation) together with HA-tagged ubiquitin and various HBc or Ub-HBc variants. The samples were analyzed as in ( A ). C , in vitro ubiquitination of Ub-HBc-wt with 400 nM UBE2O, 75 nM E1 enzyme, 5 μM ubiquitin-wt or methylated ubiquitin, as indicated. Western blotting with anti-HBc antibodies was used to visualize ubiquitinated Ub-HBc, representative of two replicates. D and E , Effect of UBE2O overexpression (in D ) or downregulation (in E ) on the secretion of various HBc and Ub-HBc variants. HepG2-NTCP cells were co-transfected with UBE2O-wt ( D ) or UBE2O-specific siRNA (si_UBE2O-B, (E)) together with various HBc and Ub-HBc variants, as indicated. The expression levels of UBE2O, HBc, and β-actin (loading control) were analyzed in the input samples (intracellular). The ability of HBc variants to assemble into capsids was determined by immunoprecipitation with anti-capsid (Hyb-3120) antibodies (IP: capsid; WB: HBc). The levels of secreted HBc and Ub-HBc were analyzed in the cell culture supernatants of transfected cells by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc antibodies (extracellular). F , comparison of UBE2O- and Alix-mediated secretion of HBc or Ub-fused HBc variants. HepG2-NTCP cells were co-transfected with Flag-Myc-UBE2O or Flag-Alix expression plasmids together with various HBc and Ub-HBc variants, as indicated. The expression levels of UBE2O, Alix, HBc, and β-actin (loading control) were analyzed in the input samples (intracellular). The levels of secreted HBc and Ub-HBc were analyzed in the cell culture supernatants of transfected cells by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc antibodies (extracellular). Graph – Quantitative analysis of secreted HBc and Ub-HBc determined by ELISA in the cell supernatants. The data are presented as means ± SDs of one experiment performed in biological replicates (n = 3) shown by orange points. Statistical significance of differences between the control and UBE2O- or Alix-transfected groups was evaluated by a two-tailed t test ( p ≥ 0.05 – not significant (ns); ∗∗ p < 0.01; ∗∗∗ p < 0.001).

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: UBE2O mediates HBc/capsid multi-monoubiquitination and secretion. A , UBE2O stimulates HBc and capsid monoubiquitination and multi-monoubiquitination. HepG2-NTCP cells were transfected with Flag-Myc-tagged UBE2O-wt (UBE2O upregulation) together with HA-tagged ubiquitin and various HBc (WT, Y132A, and S164A) or Ub-HBc (Ub-WT, Ub-Y132A, and Ub-S164A) variants. The denatured whole cell lysates were immunoprecipitated with anti-HA antibodies (IP: anti-HA) and analyzed by Western blotting with anti-hypo-pHBc antibodies. The expression levels of UBE2O, HBc, and β-actin (loading control) were analyzed in the input samples (input). B , UBE2O depletion leads to the reduction of HBc and capsid monoubiquitination and multi-monoubiquitination. HepG2-NTCP cells were transfected with UBE2O-specific siRNA (si_UBE2O-B; UBE2O downregulation) together with HA-tagged ubiquitin and various HBc or Ub-HBc variants. The samples were analyzed as in ( A ). C , in vitro ubiquitination of Ub-HBc-wt with 400 nM UBE2O, 75 nM E1 enzyme, 5 μM ubiquitin-wt or methylated ubiquitin, as indicated. Western blotting with anti-HBc antibodies was used to visualize ubiquitinated Ub-HBc, representative of two replicates. D and E , Effect of UBE2O overexpression (in D ) or downregulation (in E ) on the secretion of various HBc and Ub-HBc variants. HepG2-NTCP cells were co-transfected with UBE2O-wt ( D ) or UBE2O-specific siRNA (si_UBE2O-B, (E)) together with various HBc and Ub-HBc variants, as indicated. The expression levels of UBE2O, HBc, and β-actin (loading control) were analyzed in the input samples (intracellular). The ability of HBc variants to assemble into capsids was determined by immunoprecipitation with anti-capsid (Hyb-3120) antibodies (IP: capsid; WB: HBc). The levels of secreted HBc and Ub-HBc were analyzed in the cell culture supernatants of transfected cells by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc antibodies (extracellular). F , comparison of UBE2O- and Alix-mediated secretion of HBc or Ub-fused HBc variants. HepG2-NTCP cells were co-transfected with Flag-Myc-UBE2O or Flag-Alix expression plasmids together with various HBc and Ub-HBc variants, as indicated. The expression levels of UBE2O, Alix, HBc, and β-actin (loading control) were analyzed in the input samples (intracellular). The levels of secreted HBc and Ub-HBc were analyzed in the cell culture supernatants of transfected cells by Western blotting with anti-HBc, anti-hyper-pHBc and anti-hypo-pHBc antibodies (extracellular). Graph – Quantitative analysis of secreted HBc and Ub-HBc determined by ELISA in the cell supernatants. The data are presented as means ± SDs of one experiment performed in biological replicates (n = 3) shown by orange points. Statistical significance of differences between the control and UBE2O- or Alix-transfected groups was evaluated by a two-tailed t test ( p ≥ 0.05 – not significant (ns); ∗∗ p < 0.01; ∗∗∗ p < 0.001).

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Transfection, Ubiquitin Proteomics, Immunoprecipitation, Western Blot, Expressing, Control, In Vitro, Methylation, Over Expression, Cell Culture, Comparison, Enzyme-linked Immunosorbent Assay, Two Tailed Test

Overexpression of UBE2O-WT enhances the secretion of both naked nucleocapsids and enveloped virions in HBV-infected HepG2-NTCP cells . A , experimental design: HepG2-NTCP cells were transfected with either wild-type UBE2O (UBE2O-WT), catalytically-defective mutant (UBE2O-CD), or an empty vector (pcDNA). Two days post-transfection, the cells were infected with HBV. At 6 days post-infection, cells and culture supernatants were harvested to quantify intracellular pregenomic RNA (pgRNA), nucleocapsids, and the release of extracellular naked nucleocapsids and virions. B , protein extracts from HBV-infected HepG2-NTCP cells were subjected to Western blot analysis (input) and immunoprecipitation using anti-capsid antibodies (IP: capsid, WB: HBc). C , the levels of HBV pgRNA transcription were analyzed by RT-qPCR and normalized to the housekeeping gene, HPRT1 . D , Analysis of intracellular DNA-containing nucleocapsids in HBV-infected HepG2-NTCP cells using immunoprecipitation with anti-capsids antibodies followed by qPCR. E , UBE2O-WT upregulation enhanced enveloped virion secretion, while the UBE2O-CD mutant reduced it. Viral particles were immunoprecipitated from the culture supernatants using anti-S antibodies. The associated DNA was then isolated and quantified by qPCR. F , UBE2O-WT upregulation enhanced the secretion of naked nucleocapsids. Nucleocapsids were immunoprecipitated from the culture supernatants using anti-capsid antibodies. The associated DNA was then isolated and quantified by qPCR. In ( C–F ), data are presented as the mean ± SD from two independent experiments. Color-coded data points distinguish individual replicates from each experiment, while colored horizontal lines indicate the mean values. Statistical significance of differences between UBE2O-WT, UBE2O-CD and control (pcDNA) groups was evaluated by 2-way ANOVA ( p ≥ 0.05 – not significant (ns); ∗ p < 0.05; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001).

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: Overexpression of UBE2O-WT enhances the secretion of both naked nucleocapsids and enveloped virions in HBV-infected HepG2-NTCP cells . A , experimental design: HepG2-NTCP cells were transfected with either wild-type UBE2O (UBE2O-WT), catalytically-defective mutant (UBE2O-CD), or an empty vector (pcDNA). Two days post-transfection, the cells were infected with HBV. At 6 days post-infection, cells and culture supernatants were harvested to quantify intracellular pregenomic RNA (pgRNA), nucleocapsids, and the release of extracellular naked nucleocapsids and virions. B , protein extracts from HBV-infected HepG2-NTCP cells were subjected to Western blot analysis (input) and immunoprecipitation using anti-capsid antibodies (IP: capsid, WB: HBc). C , the levels of HBV pgRNA transcription were analyzed by RT-qPCR and normalized to the housekeeping gene, HPRT1 . D , Analysis of intracellular DNA-containing nucleocapsids in HBV-infected HepG2-NTCP cells using immunoprecipitation with anti-capsids antibodies followed by qPCR. E , UBE2O-WT upregulation enhanced enveloped virion secretion, while the UBE2O-CD mutant reduced it. Viral particles were immunoprecipitated from the culture supernatants using anti-S antibodies. The associated DNA was then isolated and quantified by qPCR. F , UBE2O-WT upregulation enhanced the secretion of naked nucleocapsids. Nucleocapsids were immunoprecipitated from the culture supernatants using anti-capsid antibodies. The associated DNA was then isolated and quantified by qPCR. In ( C–F ), data are presented as the mean ± SD from two independent experiments. Color-coded data points distinguish individual replicates from each experiment, while colored horizontal lines indicate the mean values. Statistical significance of differences between UBE2O-WT, UBE2O-CD and control (pcDNA) groups was evaluated by 2-way ANOVA ( p ≥ 0.05 – not significant (ns); ∗ p < 0.05; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001).

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Over Expression, Infection, Transfection, Mutagenesis, Plasmid Preparation, Western Blot, Immunoprecipitation, Quantitative RT-PCR, Isolation, Control

Role of UBE2O in HBc/capsid ubiquitination, maturation and virion egress. A , Model for UBE2O-HBc binding . UBE2O-mediated monoubiquitination of HBc enhances the stability of the UBE2O-HBc complex, thereby promoting the subsequent multi-monoubiquitination of HBc. B , HBV infection results in the secretion of diverse viral progeny species, including: (I) HBeAg and spherical HBsAg; (II) naked capsids (NC, genome-positive and genome-negative); (III) infectious genome-positive HBV virions, empty genome-negative HBV virions, and non-infectious empty envelope particles (subviral particles, SVPs). (I) HBeAg and spherical HBsAg are secreted via the host ER-Golgi constitutive secretory pathway. (II) The egress of naked capsids, regardless of their nucleic acid content, is facilitated by Alix via an ESCRT-independent pathway. Interaction between Alix and the NEDD4 family E3 ubiquitin ligase AIP4 drives the release of HBV naked capsids. (III) Assembly and egress of infectious or empty virions rely on the ESCRT machinery, which facilitates capsid sorting into intraluminal vesicles (ILVs) within multivesicular bodies (MVBs). Host components of the MVB pathway support capsid envelopment and virion budding. Our findings demonstrate that UBE2O, an E2/E3 ubiquitin ligase, plays a critical role in these processes. UBE2O recognizes hypophosphorylated HBc and capsids, catalyzes their mono- and multi-monoubiquitination, and facilitates the efficient release of HBV virions. (IV) Hypophosphorylated unassembled HBc is also secreted, likely utilizing the ER-Golgi constitutive secretory pathway shared with HBeAg. Images were created in BioRender.com .

Journal: The Journal of Biological Chemistry

Article Title: UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress

doi: 10.1016/j.jbc.2025.110750

Figure Lengend Snippet: Role of UBE2O in HBc/capsid ubiquitination, maturation and virion egress. A , Model for UBE2O-HBc binding . UBE2O-mediated monoubiquitination of HBc enhances the stability of the UBE2O-HBc complex, thereby promoting the subsequent multi-monoubiquitination of HBc. B , HBV infection results in the secretion of diverse viral progeny species, including: (I) HBeAg and spherical HBsAg; (II) naked capsids (NC, genome-positive and genome-negative); (III) infectious genome-positive HBV virions, empty genome-negative HBV virions, and non-infectious empty envelope particles (subviral particles, SVPs). (I) HBeAg and spherical HBsAg are secreted via the host ER-Golgi constitutive secretory pathway. (II) The egress of naked capsids, regardless of their nucleic acid content, is facilitated by Alix via an ESCRT-independent pathway. Interaction between Alix and the NEDD4 family E3 ubiquitin ligase AIP4 drives the release of HBV naked capsids. (III) Assembly and egress of infectious or empty virions rely on the ESCRT machinery, which facilitates capsid sorting into intraluminal vesicles (ILVs) within multivesicular bodies (MVBs). Host components of the MVB pathway support capsid envelopment and virion budding. Our findings demonstrate that UBE2O, an E2/E3 ubiquitin ligase, plays a critical role in these processes. UBE2O recognizes hypophosphorylated HBc and capsids, catalyzes their mono- and multi-monoubiquitination, and facilitates the efficient release of HBV virions. (IV) Hypophosphorylated unassembled HBc is also secreted, likely utilizing the ER-Golgi constitutive secretory pathway shared with HBeAg. Images were created in BioRender.com .

Article Snippet: The primary antibodies and reagents used for the Western blotting and immunoprecipitations included antibodies against UBE2O (Novus Biologicals), ubiquitin-HRP (BioLegend), HBV surface antigen (S14, Abcam), β-actin (Abcam), Flag (Sigma-Aldrich), HA (Sigma-Aldrich), α-tubulin (Sigma-Aldrich, USA), lamin A/C (Santa Cruz Biotechnologies), and anti-HA magnetic beads (ThermoFisher Scientific, USA).

Techniques: Ubiquitin Proteomics, Binding Assay, Infection

kcnb1 is expressed in distinct cell subtypes and various regions of the central nervous system in 6 days post fertilization (dpf) wild‐type (WT) zebrafish. (A, B) Horizontal and transversal sections of WT zebrafish expressing cells (4,6‐diamidino‐2‐phenylindole [DAPI]; blue) labeled with anti‐kcnb1 (green), showing a large expression of the protein in the central nervous system (CNS) at 6 dpf. The protein is expressed in the telencephalon, diencephalon, midbrain including the optic tectum, and hindbrain comprising the cerebellum and the spinal cord (A: scale bar = 50 μm, magnification = 10×; B: scale bar = 30 μm, magnification 20×). (C) Horizontal section of a WT zebrafish at 6 dpf showing the presence of kcnb1 along the spinal cord (scale bar = 10 μm, magnification = 63×). (D–F) Horizontal sections of 6‐dpf WT zebrafish expressing cells (DAPI; blue), kcnb1 (green), and specific cell subtype markers, respectively. (D) A neuronal nuclear marker (neuronal nuclear antigen [NeuN]; red, scale bar = 30 μm, magnification = 20×), (E) oligodendrocyte transcription factor 2 (Olig2; red, scale bar = 10 μm, magnification = 63×), and (F) CX3C motif chemokine receptor 1 expressed in microglial cells (CX3CR1; red, scale bar = 10 μm, magnification = 63×). Images demonstrate the colocalization between kcnb1 and the three different cell subtype markers, represented in white and marked by arrows. These results indicate the presence of kcnb1 in neurons, oligodendrocytes, and microglial cells. The colocalization was determined using Z ‐stack projection with IMARIS v10.1.0 software (Oxford Instruments). In figures, CNS regions are delimited by dotted lines. D, diencephalon; E, eyes; H, hindbrain; M: midbrain; T, telencephalon. n = 3–4/section.

Journal: Epilepsia

Article Title: kcnb1 loss of function in zebrafish causes neurodevelopmental and epileptic disorders associated with γ‐aminobutyric acid dysregulation

doi: 10.1111/epi.18407

Figure Lengend Snippet: kcnb1 is expressed in distinct cell subtypes and various regions of the central nervous system in 6 days post fertilization (dpf) wild‐type (WT) zebrafish. (A, B) Horizontal and transversal sections of WT zebrafish expressing cells (4,6‐diamidino‐2‐phenylindole [DAPI]; blue) labeled with anti‐kcnb1 (green), showing a large expression of the protein in the central nervous system (CNS) at 6 dpf. The protein is expressed in the telencephalon, diencephalon, midbrain including the optic tectum, and hindbrain comprising the cerebellum and the spinal cord (A: scale bar = 50 μm, magnification = 10×; B: scale bar = 30 μm, magnification 20×). (C) Horizontal section of a WT zebrafish at 6 dpf showing the presence of kcnb1 along the spinal cord (scale bar = 10 μm, magnification = 63×). (D–F) Horizontal sections of 6‐dpf WT zebrafish expressing cells (DAPI; blue), kcnb1 (green), and specific cell subtype markers, respectively. (D) A neuronal nuclear marker (neuronal nuclear antigen [NeuN]; red, scale bar = 30 μm, magnification = 20×), (E) oligodendrocyte transcription factor 2 (Olig2; red, scale bar = 10 μm, magnification = 63×), and (F) CX3C motif chemokine receptor 1 expressed in microglial cells (CX3CR1; red, scale bar = 10 μm, magnification = 63×). Images demonstrate the colocalization between kcnb1 and the three different cell subtype markers, represented in white and marked by arrows. These results indicate the presence of kcnb1 in neurons, oligodendrocytes, and microglial cells. The colocalization was determined using Z ‐stack projection with IMARIS v10.1.0 software (Oxford Instruments). In figures, CNS regions are delimited by dotted lines. D, diencephalon; E, eyes; H, hindbrain; M: midbrain; T, telencephalon. n = 3–4/section.

Article Snippet: After permeabilization for 30 min, the slices were incubated overnight at 4°C in blocking solution containing primary antibodies: Kcnb1 (1:100, Tebubio, #PAB7569), NeuN (1:100, Merck, #ABN90), Olig2 (1:100, DSHB, #PCRP‐OLIG2‐1E9‐s), CX3CR1 (1:100, Proteintech, #13885‐1‐AP), Ankyrin G (1:100, Proteintech, #27980‐1‐AP), and HuC (1:100, Tebubio, #FNab04072).

Techniques: Expressing, Labeling, Marker, Software

Fig. 5 | CCL17–CCR8–CCL3 axis critically interferes with Treg differentiation. a, Schematic of co-culture experiment, where isolated splenic CD4+CD62L+ T cells from Ccr8WTApoe−/− or Ccr8KOApoe−/− mice were combined with sorted CD11c+MHCII+ cDCs from LN of CCR8WTApoe−/− mice and cultured for 3 d in the absence or presence of recombinant murine CCL17 (100 ng ml−1). b, CCL3 concentrations were measured in cell supernatants by ELISA (number of independent experiments per bar from left to right, n = 7, 9, 6, 9). c, CD4+CD25+Foxp3+ Treg cells were quantified using flow cytometry analysis (number of independent experiments per bar from left to right: n = 10, 12, 10 and 13). d, Scheme of co-culture experiment, where isolated splenic CD4+CD62L+ T cells from Ccr8WTApoe−/− or Ccr8KOApoe−/−mice were combined with sorted CD11c+MHCII+ cDCs from LN of Apoe−/− or Apoe−/−Ccl17e/e mice and cultured for 3 d. e, CCL3 concentrations in the supernatant were determined by ELISA

Journal: Nature Cardiovascular Research

Article Title: Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis

doi: 10.1038/s44161-023-00413-9

Figure Lengend Snippet: Fig. 5 | CCL17–CCR8–CCL3 axis critically interferes with Treg differentiation. a, Schematic of co-culture experiment, where isolated splenic CD4+CD62L+ T cells from Ccr8WTApoe−/− or Ccr8KOApoe−/− mice were combined with sorted CD11c+MHCII+ cDCs from LN of CCR8WTApoe−/− mice and cultured for 3 d in the absence or presence of recombinant murine CCL17 (100 ng ml−1). b, CCL3 concentrations were measured in cell supernatants by ELISA (number of independent experiments per bar from left to right, n = 7, 9, 6, 9). c, CD4+CD25+Foxp3+ Treg cells were quantified using flow cytometry analysis (number of independent experiments per bar from left to right: n = 10, 12, 10 and 13). d, Scheme of co-culture experiment, where isolated splenic CD4+CD62L+ T cells from Ccr8WTApoe−/− or Ccr8KOApoe−/−mice were combined with sorted CD11c+MHCII+ cDCs from LN of Apoe−/− or Apoe−/−Ccl17e/e mice and cultured for 3 d. e, CCL3 concentrations in the supernatant were determined by ELISA

Article Snippet: Mouse CD4+ T cells from Apoe−/−, Ccr8WTApoe−/− or Ccr8KOApoe−/− mice or human CD4+ T cells (1 × 105) were added to the top chamber in the presence or absence of CCR4 receptor antagonist C 021 dihydrochloride (Tocris) at a concentration of 0.5 μM; or human CD4+ T cells (1 × 105) were pretreated with or without anti-CCR8 antibody (R&D Systems) and added to the top chamber and allowed to migrate for 3 h. The number of cells migrated was analyzed by flow cytometry (FACSCanto II, BD Biosciences) and FlowJo v.10 software (Tree Star).

Techniques: Co-Culture Assay, Isolation, Cell Culture, Recombinant, Enzyme-linked Immunosorbent Assay, Flow Cytometry